Loading
CC
Cadus Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by ICAHN CARL C, was filed 28 Jun 2018.
Cadus Corp: what insiders have been doing
Cadus Corp is a listed company. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for Cadus Corp. The previous disclosure was published on 28 June 2018.
Since 2007, the database holds 71 purchases and 10 sales by insiders of the company.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
84
Thresholds
n/a
Buy Volume
€13M
71 ops. · all time
Sell Volume
€2M
10 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
Net income-2.4M
Last declaration on 28 June 2018
Declarations84 total
8,463,402 shares@ US$1.61100.0% of flowCommon Stock, $0.01 par valueSEC:0001144204-18-036386:0
Canonical exit: 26 Sept 2018 (T+90)
5,000 shares@ US$1.61100.0% of flowCommon Stock, $0.01 par valueSEC:0001144204-18-036388:0
8,834 shares@ US$1.61100.0% of flowCommon Stock, $0.01 par valueSEC:0001144204-18-036392:0
10,000 shares@ US$1.61100.0% of flowCommon Stock, $0.01 par valueSEC:0001144204-18-036395:0
900 shares@ US$1.45Common StockSEC:0001144204-14-071743:0
Canonical exit: 1 Mar 2015 (T+90)
400 shares@ US$1.48Common StockSEC:0001144204-14-071743:1
Canonical exit: 1 Mar 2015 (T+90)
2,000 shares@ US$1.49Common StockSEC:0001144204-14-071743:2
Canonical exit: 1 Mar 2015 (T+90)
5,000 shares@ US$1.48Common StockSEC:0001144204-14-071741:0
Canonical exit: 1 Mar 2015 (T+90)
200 shares@ US$1.51Common StockSEC:0001144204-14-051775:0
Canonical exit: 17 Nov 2014 (T+90)
3,125 shares@ US$1.52Common StockSEC:0001144204-14-051775:1
Canonical exit: 17 Nov 2014 (T+90)
6,675 shares@ US$1.55Common StockSEC:0001144204-14-051775:2
Canonical exit: 17 Nov 2014 (T+90)
12,563,840 shares@ US$1.53Common Stock, $0.01 par value ("Shares")SEC:0001140361-14-024915:0
1,452,538 shares@ US$1.45Common StockSEC:0001144204-13-052450:0
5,400 shares@ US$1.45Common StockSEC:0001144204-13-050064:0
11,412 shares@ US$1.45Common StockSEC:0001144204-13-050064:1
250,000 shares@ US$1.43Common StockSEC:0001144204-13-013905:0
50,000 shares@ US$1.35Common StockSEC:0001144204-10-066570:0
50,000 shares@ US$1.35Common StockSEC:0001144204-10-065432:0
Canonical exit: 6 Mar 2011 (T+90)
900 shares@ US$1.50Common Stock, $0.10 par value ("Shares")SEC:0001144204-09-016385:0
Canonical exit: 22 Jun 2009 (T+90)
900 shares@ US$1.50SharesSEC:0001144204-09-016385:1
Canonical exit: 23 Jun 2009 (T+90)
900 shares@ US$1.50SharesSEC:0001144204-09-016385:2
Canonical exit: 24 Jun 2009 (T+90)
1,100 shares@ US$1.55Common Stock, $0.10 par value ("Shares")SEC:0001144204-09-015709:0
Canonical exit: 17 Jun 2009 (T+90)
1,100 shares@ US$1.46Common Stock, $0.10 par value ("Shares")SEC:0001144204-09-014876:0
Canonical exit: 14 Jun 2009 (T+90)
500 shares@ US$1.46SharesSEC:0001144204-09-014876:1
Canonical exit: 16 Jun 2009 (T+90)
264,180 shares@ US$1.45Common Stock, $0.10 par value ("Shares")SEC:0000928475-09-000136:0
Canonical exit: 10 Jun 2009 (T+90)
25 of 84 declarations
About Cadus Corp
Cadus Corp is a publicly traded company on NASDAQ, focused on developing innovative solutions in the healthcare sector. It specializes in the research and commercialization of pharmaceutical and biopharmaceutical products.
